Priyanka Jaju Acquires Convertible Warrants in Godavari Drugs Ltd.
Godavari Drugs Limited announced that Priyanka Jaju, a promoter of the company, acquired 1,00,000 convertible warrants through a preferential issue on March 18, 2026.The acquisition was made via preferential allotment. Prior to the acquisition, Jaju held 1,85,000 shares representing 2.46% of the company's total share/voting capital. Following the acquisition of the warrants, Jaju's holding increased, with a total of 2,85,000 shares representing 1.83% of the company’s total share/voting capital and 2.28% in warrants.
Godavari Drugs Limited’s total share capital stands at Rs. 7,53,05,000, divided into 75,30,500 fully paid-up equity shares of Rs. 10 each. The total diluted share/voting capital of the company is Rs. 12,48,75,000, divided into 1,24,87,500 fully paid-up equity shares of Rs. 10 each.
Source:
Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.